At our April Speaking of Science, hematologist-oncologist M. Lia Palomba explored how the immune system is being used to fight cancer.
Dr. M. Lia Palomba is a hematologist-oncologist at Memorial Sloan Kettering Cancer Center who specializes in the study and treatment of lymphoma. Her work focuses on the development of novel therapies for patients with B cell lymphoma, including indolent lymphomas (follicular, marginal zone, small lymphocytic), Waldenström’s macroglobulinemia, and chronic lymphocytic leukemia, as well as aggressive lymphoma, such as diffuse large-B cell lymphoma.
Dr. Palomba’s research interest is in tumor immunology, and she is involved in the development of novel therapies that exploit the immune system as a way to treat cancer. She is the head of hematological malignancies for the Cellular Therapeutics Center, which has played a fundamental role in the development and implementation of CAR T cell therapy. She is also interested in developing targeted therapies for lymphoma and in understanding the mechanisms by which these therapies work.
